US$ 26.11
glp-1 agonists with cardiovascular benefit Effects of Glucagon-Like Peptide-1 Receptor GLP-1 Receptor Agonists in Heart
Description
What should readers know about va glp 1 coverage

Methodology Study design This study is a systematic review and meta-analysis of cardiovascular outcome trials (CVOTs) evaluating the long-term safety and efficacy of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in populations at high cardiovascular risk

[Accessed 16th April 2026]

C., Amiel, S